| |
 |
Editorial [ DNA Repair as a Target for Anti-Cancer Therapy Guest Editor: Robert M. Brosh Jr. ]
 |
| |
|
pp.350-350 (1) Author: Robert M. Brosh, Jr. |
| |
|
|
| |
|
Targeting Base Excision Repair for Chemosensitization
|
| |
|
pp.351-357 (7) Authors: Sanjay Adhikari, Sujata Choudhury, Partha S. Mitra, Jerita J. Dubash, Shyama P. Sajankila, Rabindra Roy |
| |
|
|
| |
|
Polynucleotide Kinase as a Potential Target for Enhancing Cytotoxicity by Ionizing Radiation and Topoisomerase I Inhibitors
|
| |
|
pp.358-367 (10) Authors: N. K. Bernstein, F. Karimi-Busheri, A. Rasouli-Nia, R. Mani, G. Dianov, J. N.M. Glover, M. Weinfeld |
| |
|
|
| |
|
Role of Mismatch Repair and MGMT in Response to Anticancer Therapies
 |
| |
|
pp.368-380 (13) Authors: Ida Casorelli, Maria Teresa Russo, Margherita Bignami |
| |
|
|
| |
|
Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy
|
| |
|
pp.381-389 (9) Authors: Thomas S. Dexheimer, Smitha Antony, Christophe Marchand, Yves Pommier |
| |
|
|
| |
|
Helicases as Prospective Targets for Anti-Cancer Therapy
|
| |
|
pp.390-401 (12) Authors: Rigu Gupta, Robert M. Brosh, Jr. |
| |
|
|
| |
|
Targeting Poly (ADP) Ribose Polymerase I (PARP-1) and PARP-1 Interacting Proteins for Cancer Treatment
|
| |
|
pp.402-416 (15) Authors: Elza T. Sakamoto-Hojo, Adayabalam S. Balajee |
| |
|
|
| |
|
DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
|
| |
|
pp.417-425 (9) Authors: Mark R. Kelley, Melissa L. Fishel |
| |
|
|
| |
|
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
|
| |
|
pp.426-430 (5) Authors: Rachel Litman, Rigu Gupta, Robert M. Brosh, Jr., Sharon B. Cantor |
| |
|
|
| |
|
Repair and Translesion DNA Polymerases as Anticancer Drug Targets
|
| |
|
pp.431-447 (17) Authors: Giovanni Maga, Ulrich Hubscher |
| |
|
|
| |
|
Therapeutic Exploitation of Tumor Cell Defects in Homologous Recombination
|
| |
|
pp.448-460 (13) Authors: Simon N. Powell, Lisa A. Kachnic |
| |
|
|
